Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Sep 27, 2021; 13(9): 1079-1094
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1079
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1079
Table 1 Patient profile of included studies (distribution, age, sex, and pathology)
| Ref. | Number | Age | Sex (M/F) | Pathology | |||||
| Steroid | Control | Steroid | Control | Steroid | Control | Steroid | Control | ||
| Donadon et al[13], 2016 | 16 | 16 | 65 (27-80)1 | 63 (22-77)1 | 10/6 | 9/7 | Metastasis | 6 | 12 |
| HCC | 6 | 2 | |||||||
| Cholangiocarcinoma | 4 | 0 | |||||||
| Others | 0 | 2 | |||||||
| Hasegawa et al[15], 2020 | 50 | 50 | 67 (59-74)2 | 68 (62–75)2 | 30/20 | 31/19 | Metastasis | 21 | 14 |
| Hayashi et al[12], 2011 | 102 | 98 | 69 (39-81)1 | 70 (35-82)1 | - | - | Metastasis | 32 | 23 |
| HCC | 63 | 66 | |||||||
| Cholangiocarcinoma | 6 | 5 | |||||||
| Others | 1 | 4 | |||||||
| Muratore et al[20], 2003 | 25 | 28 | 65.4 ± 10.83 | 64.1 ± 11.73 | 8/17 | 11/17 | - | - | - |
| Pulitanò et al[17], 2007 | 37 | 36 | 63 (31-85)4 | 61.8 (21-78)4 | 23/14 | 22/14 | Metastasis | 16 | 14 |
| HCC | 12 | 14 | |||||||
| Cholangiocarcinoma | 5 | 4 | |||||||
| Hemangioendothelioma | 1 | 1 | |||||||
| Benign | 3 | 3 | |||||||
| Schmidt et al[18], 2007 | 10 | 10 | 575 | 655 | 3/7 | 4/6 | HCC | 2 | 1 |
| Metastasis | 4 | 4 | |||||||
| Cholangiocarcinoma | 0 | 2 | |||||||
| Benign | 4 | 3 | |||||||
| Yamashita et al[16], 2001 | 17 | 16 | 60.3 ± 1.86 | 56.8 ± 3.96 | 4/13 | 11/5 | HCC | 13 | 8 |
| Metastasis | 0 | 3 | |||||||
| Cholangiocarcinoma | 0 | 1 | |||||||
| Living donor of transplant | 4 | 4 | |||||||
| Zi et al[19], 2015 | 40 | 39 | 57.55 ± 8.813 | 57.51 ± 10.323 | 23/17 | 17/22 | Malignant | 31 | 34 |
| Benign | 9 | 5 | |||||||
Table 2 Surgical details of included studies (type of resection, duration, blood loss and volume resected)
| Ref. | Type of resection | Duration of operation/min | Volume of blood loss/mL | Volume of liver resected/g | |||||
| Steroid | Control | Steroid | Control | Steroid | Control | Steroid | Control | ||
| Donadon et al[13], 2016 | Minor | 9 | 11 | 383.5 (235-546)1 | 351 (226-640)1 | 275 (100-1000)1 | 200 (0-700)1 | - | - |
| Major | 7 | 5 | |||||||
| Hasegawa et al[15], 2020 | Minor | 40 | 39 | 215 (170-294)2 | 233 (157-270)2 | 52 (29-149)2 | 34 (17-76)2 | - | - |
| Major | 10 | 11 | |||||||
| Hayashi et al[12], 2011 | Hemihepactectomy | 11 | 15 | 330 (165-834)1 | 316 (136-697)1 | 324 (5-1577)1 | 257 (10-1972)1 | 77 (4-1930)1 | 75 (6-1300)1 |
| Segmentectomy | 59 | 57 | |||||||
| Limited resection | 32 | 26 | |||||||
| Muratore et al[20], 2003 | Minor | 12 | 13 | - | - | 322.8 ± 261.43 | 294.6 ± 271.93 | - | - |
| Major | 13 | 15 | |||||||
| Pulitanò et al[17], 2007 | Right hepactectomy | 11 | 10 | 440 (220-480)1 | 408 (240-460)1 | 662 (300-800)1 | 621 (350-720)1 | 40.4 ± 203 (%) | 39.5 ± 183 (%) |
| Left hepatectomy | 6 | 8 | |||||||
| Extended right hepatectomy | 5 | 4 | |||||||
| Extended left hepatectomy | 2 | 2 | |||||||
| Bisegmentectomy | 6 | 4 | |||||||
| Segmentectomy | 4 | 5 | |||||||
| Wedge resection | 3 | 3 | |||||||
| Schmidt et al[18], 2007 | Segment II/III | 4 | 5 | 2224 | 2524 | 3404 | 7804 | - | - |
| Segment V-VIII | 6 | 5 | |||||||
| Yamashita et al[16], 2001 | Lobectomy or more | 5 | 6 | 338 ± 215 | 352 ± 145 | 892 ± 1065 | 822 ± 555 | 239 ± 505 | 187 ± 335 |
| Segmentectomy | 2 | 1 | |||||||
| Subsegmentectomy or less | 10 | 9 | |||||||
| Zi et al[19], 2015 | Major | 22 | 12 | 342.38 ± 129.733 | 353.21 ± 168.363 | 481.25 ± 415.983 | 496.15 ± 391.593 | - | - |
| Minor | 18 | 27 | |||||||
Table 3 Perioperative steroid protocols of included studies
| Ref. | Study design | Country | Steroid protocol | Control protocol |
| Donadon et al[13], 2016 | RCT | Italy | Preoperative bolus infusion (5%) of 500 mg methylprednisolone in 250 mL glucose for 1 h prior to hepatectomy, then continuous infusion for 6 h | 250 mL glucose-5% as bolus and subsequent continuous infusion |
| Hasegawa et al[15], 2020 | RCT | Japan | Preoperative, up to 500 mg methylprednisolone in saline solution | Saline only |
| Hayashi et al[12], 2011 | RCT | Japan | Intraoperative 500 mg hydrocortisone immediately prior to hepatic-pedicle clamping 300 mg hydrocortisone on POD1 200 mg on POD 2, 100 mg on POD3 | 0 |
| Muratore et al[20], 2003 | RCT | Italy | Preoperative (30 min before surgery) 30 mg/kg per body weight IV methylprednisolone | 0 |
| Pulitanòet al[17], 2007 | RCT | Italy | Preoperative 500 mg methylprednisolone | 0 |
| Schmidt et al[18], 2007 | RCT | Germany | Preoperative (90 min before surgery) 30 mg/kg per body weight IV methylprednisolone | 50 mL IV saline |
| Yamashita et al[16], 2001 | RCT | Japan | Preoperative (2 h before surgery) 500 mg IV methylprednisolone | 0 |
| Zi et al[19], 2015 | RCT | China | Intraoperative 500 mg methylprednisolone prior to liver resection | Hepatectomy only |
- Citation: Hai HH, Aw P, Teng TZJ, Shelat VG. Perioperative steroid administration reduces overall complications in patients undergoing liver resection: A meta-analysis. World J Gastrointest Surg 2021; 13(9): 1079-1094
- URL: https://www.wjgnet.com/1948-9366/full/v13/i9/1079.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i9.1079
